Standout Papers

Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma 2024 202654
  1. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma (2024)
    Feng Zhang, Suiyi Wu et al. Cancer Communications

Citation Impact

70 standout
Sub-graph 1 of 21

Citing Papers

Multi-OMICS approaches in cancer biology: New era in cancer therapy
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
2 intermediate papers

Works of Jun-Xian Du being referenced

Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1
2021
MiR ‐3613‐3p from carcinoma‐associated fibroblasts exosomes promoted breast cancer cell proliferation and metastasis by regulating SOCS2 expression
2020

Author Peers

Author Molecular Biology Cancer Research PRM Oncology Last Decade Papers Cites
Jun-Xian Du 297 190 47 64 20 369
Zebiao Gan 17 326
Richard R. Klink 2 25 1.5k
Sergey Eyderman 1 14 388
Ying‐Chan Tang 7 289
Peter J. Hynds 307 62 1 44 6 389

All Works

Loading papers...

Rankless by CCL
2026